Andes Technology Corp (6533)
Taiwan Stock Exchange · Taiwan · prices in TWD · close of 22 Oct 2026
Key indicators
| Last close | TWD 282.50 |
|---|---|
| 52-week range | 170.00 – 366.50 |
| Return, 1 month / 3 months | +11.0% / +20.5% |
| Return, 1 year / 3 years | +1.3% / −29.1% |
| Trend | Uptrend |
| RSI (14) | 46 |
| Volatility (1 year) | 58.7% |
| Worst drawdown (1 year) | -41.7% |
| Average daily value traded | 721.84M TWD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Andes Technology is a semiconductor intellectual property company based in Hsinchu, Taiwan. It designs processor cores and related hardware and software development tools, licensing this technology to chip designers and system companies that build integrated circuits. Its customers use these processor designs in embedded applications across consumer electronics, networking and industrial equipment. The company also offers support services that help customers integrate its processor technology into their own chip designs.
On this site Andes Technology Corp appears as a stock on the Taiwan Stock Exchange (Taiwan), code 6533, with prices in New Taiwan dollars (TWD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Andes Technology Corp (6533) trades on the Taiwan Stock Exchange in Taiwan. It last closed at TWD 282.50 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 369 of 1,101 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.3% and over the last three months it rose 20.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Taiwan Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 21.4% | ||
| From 52-week high | -22.9% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 20.5% | ||
| 6-month return | 11.4% | ||
| 12-month return, skipping the last month | -8.8% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.7% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 721.84M TWD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −4.1% |
|---|---|
| 1 month | +11.0% |
| 3 months | +20.5% |
| 6 months | +11.4% |
| 1 year | +1.3% |
| 3 years | −29.1% |
| 5 years | −42.7% |
Signals
| 50-day / 200-day average | 276.17 / 232.65 |
|---|---|
| Golden / death cross (60 days) | Golden, 31 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 20.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Jun 2023 | TWD 1.4620 |
| 22 Jun 2022 | TWD 2.7767 |
| 11 Jun 2021 | TWD 0.7228 |
| 13 Jul 2020 | TWD 0.3315 |
| 15 Jul 2019 | TWD 0.6794 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Taiwan Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.